4/A

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: March 15, 2005
Period of Report: June 3, 2004
Accession Number: 0001291892-05-000014

View Document ↗ View on SEC.gov ↗